Interaction of Cyclin-Dependent Kinase 12/CrkRS with Cyclin K1 Is Required for the Phosphorylation of the C-Terminal Domain of RNA Polymerase II

ABSTRACT CrkRS (Cdc2-related kinase, Arg/Ser), or cyclin-dependent kinase 12 (CKD12), is a serine/threonine kinase believed to coordinate transcription and RNA splicing. While CDK12/CrkRS complexes were known to phosphorylate the C-terminal domain (CTD) of RNA polymerase II (RNA Pol II), the cyclin regulating this activity was not known. Using immunoprecipitation and mass spectrometry, we identified a 65-kDa isoform of cyclin K (cyclin K1) in endogenous CDK12/CrkRS protein complexes. We show that cyclin K1 complexes isolated from mammalian cells contain CDK12/CrkRS but do not contain CDK9, a presumed partner of cyclin K. Analysis of extensive RNA-Seq data shows that the 65-kDa cyclin K1 isoform is the predominantly expressed form across numerous tissue types. We also demonstrate that CDK12/CrkRS is dependent on cyclin K1 for its kinase activity and that small interfering RNA (siRNA) knockdown of CDK12/CrkRS or cyclin K1 has similar effects on the expression of a luciferase reporter gene. Our data suggest that cyclin K1 is the primary cyclin partner for CDK12/CrkRS and that cyclin K1 is required to activate CDK12/CrkRS to phosphorylate the CTD of RNA Pol II. These properties are consistent with a role of CDK12/CrkRS in regulating gene expression through phosphorylation of RNA Pol II.

[1]  Peter J. Shepard,et al.  The SR protein family , 2009, Genome Biology.

[2]  J. Derisi,et al.  HMMSplicer: A Tool for Efficient and Sensitive Discovery of Known and Novel Splice Junctions in RNA-Seq Data , 2010, PloS one.

[3]  L. Johnson,et al.  The structure of P‐TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation , 2008, The EMBO journal.

[4]  J. Liu,et al.  Evolution of cyclin-dependent kinases (CDKs) and CDK-activating kinases (CAKs): differential conservation of CAKs in yeast and metazoa. , 2000, Molecular biology and evolution.

[5]  A. Genevière,et al.  CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing. , 2007, Biochemical and biophysical research communications.

[6]  G. Cagney,et al.  Methylation of Histone H3 by Set2 in Saccharomyces cerevisiae Is Linked to Transcriptional Elongation by RNA Polymerase II , 2003, Molecular and Cellular Biology.

[7]  N. Sherman,et al.  Protein Sequencing and Identification Using Tandem Mass Spectrometry: Kinter/Tandem Mass Spectrometry , 2000 .

[8]  P. Stiegler,et al.  Activation of MyoD-dependent transcription by cdk9/cyclin T2 , 2002, Oncogene.

[9]  A. Levine,et al.  Identification of a novel p53 functional domain that is necessary for efficient growth suppression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Alan G Hinnebusch,et al.  Phosphorylation of the Pol II CTD by KIN28 enhances BUR1/BUR2 recruitment and Ser2 CTD phosphorylation near promoters. , 2009, Molecular cell.

[11]  A. Giordano,et al.  RB and cell cycle progression , 2006, Oncogene.

[12]  M. Mathews,et al.  Human and Rodent Transcription Elongation Factor P-TEFb: Interactions with Human Immunodeficiency Virus Type 1 Tat and Carboxy-Terminal Domain Substrate , 1999, Journal of Virology.

[13]  Qintong Li,et al.  Cyclin K-containing Kinase Complexes Maintain Self-renewal in Murine Embryonic Stem Cells* , 2012, The Journal of Biological Chemistry.

[14]  Jernej Ule,et al.  The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. , 2011, Genes & development.

[15]  A. Baldi,et al.  Cyclin T: Three forms for different roles in physiological and pathological functions , 2003, Journal of cellular physiology.

[16]  S. Buratowski,et al.  Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3' end processing. , 2004, Molecular cell.

[17]  A. Shilatifard,et al.  Bur1/Bur2 and the Ctk Complex in Yeast: The Split Personality of Mammalian P-TEFb , 2006, Cell cycle.

[18]  A. Giordano,et al.  Role of the cyclin-dependent kinase 9-related pathway in mammalian gene expression and human diseases , 2008, Cell cycle.

[19]  C. Slaughter,et al.  Casein Kinase 2 Interacts with Cyclin-dependent Kinase 11 (CDK11) in Vivo and Phosphorylates Both the RNA Polymerase II Carboxyl-terminal Domain and CDK11 in Vitro * , 2003, The Journal of Biological Chemistry.

[20]  Konrad Büssow,et al.  Characterization of Cyclin L2, a Novel Cyclin with an Arginine/Serine-rich Domain , 2004, Journal of Biological Chemistry.

[21]  B. Peterlin,et al.  P-TEFb Containing Cyclin K and Cdk9 Can Activate Transcription via RNA* , 2002, The Journal of Biological Chemistry.

[22]  M. Mathews,et al.  Three RNA Polymerase II Carboxyl-terminal Domain Kinases Display Distinct Substrate Preferences* , 2001, The Journal of Biological Chemistry.

[23]  S. Elledge,et al.  Human Cyclin K, a Novel RNA Polymerase II-Associated Cyclin Possessing Both Carboxy-Terminal Domain Kinase and Cdk-Activating Kinase Activity , 1998, Molecular and Cellular Biology.

[24]  A. Namane,et al.  Protein sequencing and identification using tandem mass spectrometry. Edited by Michael Kinter, Nicholas E. Sherman, published by Wiley-Interscience Series on Mass Spectrometry, 2000, 301 p. , 2002 .

[25]  N. Krogan,et al.  Transitions in RNA polymerase II elongation complexes at the 3′ ends of genes , 2004, The EMBO journal.

[26]  Y. Even,et al.  CDC2L5, a Cdk‐like kinase with RS domain, interacts with the ASF/SF2‐associated protein p32 and affects splicing in vivo , 2006, Journal of cellular biochemistry.

[27]  Karen E. Knudsen,et al.  AR, the cell cycle, and prostate cancer , 2008, Nuclear Receptor Signaling.

[28]  Tony Pawson,et al.  Modification of the Creator recombination system for proteomics applications – improved expression by addition of splice sites , 2006, BMC biotechnology.

[29]  Kris Thielemans,et al.  Characterization of CD8+ T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMixDC-MEL) , 2013, BioMed research international.

[30]  J. Stiller,et al.  Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs , 2004, Proceedings. 2004 IEEE Computational Systems Bioinformatics Conference, 2004. CSB 2004..

[31]  Junmin Peng,et al.  Tat Modifies the Activity of CDK9 To Phosphorylate Serine 5 of the RNA Polymerase II Carboxyl-Terminal Domain during Human Immunodeficiency Virus Type 1 Transcription , 2000, Molecular and Cellular Biology.

[32]  Steven J. M. Jones,et al.  Alternative expression analysis by RNA sequencing , 2010, Nature Methods.

[33]  E. Palescandolo,et al.  Pkn Is a novel partner of cyclin T2a in muscle differentiation , 2006, Journal of cellular physiology.

[34]  P. Mead,et al.  CDK9/cyclin complexes modulate endoderm induction by direct interaction with Mix.3/mixer , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  J. Lis,et al.  CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. , 2010, Genes & development.

[36]  G. Rubin,et al.  Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Keogh,et al.  Bur1 Kinase Is Required for Efficient Transcription Elongation by RNA Polymerase II , 2003, Molecular and Cellular Biology.

[38]  J. Pines,et al.  CrkRS: a novel conserved Cdc2-related protein kinase that colocalises with SC35 speckles. , 2001, Journal of cell science.

[39]  M. Kasten,et al.  Regulatory functions of Cdk9 and of cyclin T1 in HIV Tat transactivation pathway gene expression , 1999, Journal of cellular biochemistry.

[40]  Junmin Peng,et al.  Cyclin K Functions as a CDK9 Regulatory Subunit and Participates in RNA Polymerase II Transcription* , 1999, The Journal of Biological Chemistry.

[41]  A. Mayeda,et al.  CDK11 Complexes Promote Pre-mRNA Splicing* , 2003, The Journal of Biological Chemistry.

[42]  Hung-Hsi Chen,et al.  Identification and Characterization of the CDK12/Cyclin L1 Complex Involved in Alternative Splicing Regulation , 2006, Molecular and Cellular Biology.

[43]  Melissa J. Moore,et al.  Pre-mRNA Processing Reaches Back toTranscription and Ahead to Translation , 2009, Cell.

[44]  Chao Zhang,et al.  TFIIH-Associated Cdk7 Kinase Functions in Phosphorylation of C-Terminal Domain Ser7 Residues, Promoter-Proximal Pausing, and Termination by RNA Polymerase II , 2009, Molecular and Cellular Biology.

[45]  E. Kremmer,et al.  Phosphorylation by cyclin-dependent kinase-9 controls ubiquitin-conjugating enzyme-2A function , 2012, Cell cycle.

[46]  A. Neiman,et al.  BUR1 and BUR2 Encode a Divergent Cyclin-Dependent Kinase–Cyclin Complex Important for Transcription In Vivo , 2000, Molecular and Cellular Biology.

[47]  C. H. Herrmann,et al.  Differential localization and expression of the Cdk9 42k and 55k isoforms , 2005, Journal of cellular physiology.

[48]  Xiaohong Zhou,et al.  The proline-rich domain and the microtubule binding domain of protein tau acting as RNA binding domains. , 2006, Protein and peptide letters.

[49]  P. Loyer,et al.  Characterization of Cyclin L1 and L2 Interactions with CDK11 and Splicing Factors , 2008, Journal of Biological Chemistry.

[50]  Victor V. Solovyev,et al.  SpliceDB: database of canonical and non-canonical mammalian splice sites , 2001, Nucleic Acids Res..

[51]  John T. Lis,et al.  Defining mechanisms that regulate RNA polymerase II transcription in vivo , 2009, Nature.

[52]  S. Buratowski.  Progression through the RNA polymerase II CTD cycle. , 2009, Molecular cell.

[53]  Y. Shyr,et al.  Cyclin‐dependent kinase 9–cyclin K functions in the replication stress response , 2010, EMBO reports.

[54]  A. Inoue,et al.  Failure To Proliferate and Mitotic Arrest of CDK11p110/p58-Null Mutant Mice at the Blastocyst Stage of Embryonic Cell Development , 2004, Molecular and Cellular Biology.

[55]  B. Mayer,et al.  SH3 domains: complexity in moderation. , 2001, Journal of cell science.

[56]  J. Ladias,et al.  Crystal structure of human cyclin K, a positive regulator of cyclin-dependent kinase 9. , 2007, Journal of molecular biology.

[57]  A. Giordano,et al.  Distinct regions of cyclinT1 are required for binding to CDK9 and for recruitment to the HIV‐1 Tat/TAR complex , 2001, Journal of cellular biochemistry. Supplement.

[58]  R. Fisher.  Secrets of a double agent: CDK7 in cell-cycle control and transcription , 2005, Journal of Cell Science.

[59]  Shona Murphy,et al.  Cracking the RNA polymerase II CTD code. , 2008, Trends in genetics : TIG.

[60]  D. Price,et al.  Identification of a novel isoform of Cdk9. , 2003, Gene.

[61]  P. Dent,et al.  Characterization of Cdk9(55) and differential regulation of two Cdk9 isoforms. , 2005, Gene.

[62]  Yusuke Nakamura,et al.  Cyclin K as a direct transcriptional target of the p53 tumor suppressor. , 2002, Neoplasia.

[63]  B. Peterlin,et al.  Controlling the elongation phase of transcription with P-TEFb. , 2006, Molecular cell.

[64]  D. Bentley,et al.  "Cotranscriptionality": the transcription elongation complex as a nexus for nuclear transactions. , 2009, Molecular cell.

[65]  D. Mitra,et al.  Cyclin K Inhibits HIV-1 Gene Expression and Replication by Interfering with Cyclin-dependent Kinase 9 (CDK9)-Cyclin T1 Interaction in Nef-dependent Manner* , 2011, The Journal of Biological Chemistry.

[66]  Y. Ohkuma,et al.  Phosphorylation of the C-terminal domain of RNA polymerase II plays central roles in the integrated events of eucaryotic gene expression. , 2007, Journal of biochemistry.

[67]  Tina Lenasi,et al.  P-TEFb stimulates transcription elongation and pre-mRNA splicing through multilateral mechanisms , 2010, RNA biology.

[68]  M. Malumbres,et al.  Cyclins and related kinases in cancer cells. , 2007, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.